Jose Saro MD
About Jose Saro MD
Jose Saro, MD, serves as the Vice President of Global Clinical Development at Adaptimmune, where he has worked since 2021. He has extensive experience in oncology, having held leadership roles at several major pharmaceutical companies and developed a global network of oncologic academic institutions.
Current Role at Adaptimmune
Jose Saro serves as the Vice President of Global Clinical Development at Adaptimmune, a position he has held since 2021. In this role, he is responsible for overseeing clinical development strategies and operations, focusing on advancing innovative therapies in oncology. His leadership is instrumental in driving the company's clinical programs and ensuring alignment with regulatory requirements.
Previous Experience in Oncology R&D
Prior to his current role, Jose Saro held significant positions in various pharmaceutical companies. He worked at Bristol-Myers Squibb as Executive Director of Oncology R&D from 2009 to 2013 in the Paris Area, France. He then transitioned to Roche, where he served as a Senior Leader in Translational Medicine at the Zurich Roche Innovation Center from 2013 to 2018, focusing on cancer immunotherapy. His experience also includes a role as Senior Medical Director at AstraZeneca from 2020 to 2021 in Cambridgeshire, England.
Leadership at Avacta
Jose Saro was the Chief Medical Officer at Avacta from 2018 to 2020 in Cambridge, United Kingdom. During his tenure, he contributed to the development of innovative therapeutic approaches in oncology, leveraging his extensive background in clinical development and translational medicine.
Educational Background and Qualifications
Jose Saro holds a medical degree (MD) from Universidad de Oviedo and has studied Pharmaceutical Medicine, achieving a Master's degree from Universidad Complutense de Madrid. Additionally, he completed studies at Stellenbosch University, where he obtained the Mb CHb qualification. His educational background supports his extensive expertise in clinical development and oncology.
Expertise in Oncology and Clinical Development
Jose Saro possesses a broad scientific and management experience in oncology translational medicine. He has developed an extensive global network of oncologic academic institutions and has achieved key milestones in clinical development. His work supports various aspects of drug development, including regulatory compliance, sales, marketing, pricing, and reimbursement strategies.